New Stock News | Xinde Technology Files for Hong Kong Stock Exchange Listing a Second Time

According to a disclosure by the Hong Kong Stock Exchange on October 14, Shandong Xinde Technology Co., Ltd. (referred to as: Xinde Technology) has submitted a listing application to the Main Board of the Hong Kong Stock Exchange, with Zhongtai International acting as its sole sponsor. This is the company's second submission of a listing application to the Hong Kong Stock Exchange. The prospectus shows that Xinde Technology was established in 1999 and is an animal health company in China. The company is primarily engaged in the research and development, production, and sales of a full range of animal health and ancillary products, with products covering veterinary biological products (such as vaccines, antibodies, transfer factors, etc.), traditional Chinese veterinary medicines, chemical drug preparations, feed and feed additives, achieving the prevention, diagnosis, treatment, and control of diseases in poultry, livestock, aquatic animals, and pets. During the track record period, most of the company's revenue came from the sales of animal health and ancillary products.